» Authors » Rainer Broll

Rainer Broll

Explore the profile of Rainer Broll including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmidt M, Broll R, Bruch H, Duchrow M
Histochem Cell Biol . 2018 Nov; 151(3):275. PMID: 30460406
In the PubMed citation records, the author's name shows.
2.
Windhovel U, Haasper C, Duchrow M, Bruch H, Broll R
Anticancer Res . 2005 Mar; 24(6):3789-94. PMID: 15736413
Background: Cyclooxygenase (COX)-2 is overexpressed in several tumor entities and seems to play a key role in carcinogenesis. This makes it a potential target in cancer therapy. Materials And Methods:...
3.
Ihmann T, Liu J, Schwabe W, Hausler P, Behnke D, Bruch H, et al.
J Cancer Res Clin Oncol . 2004 Sep; 130(12):749-56. PMID: 15449182
Purpose: The present study retrospectively examines the expression of pKi-67 mRNA and protein in colorectal carcinoma and their correlation to the outcome of patients. Methods: Immunohistochemistry and quantitative RT-PCR were...
4.
Buban T, Schmidt M, Broll R, Antal-Szalmas P, Duchrow M
Cancer Genet Cytogenet . 2004 Apr; 149(1):81-4. PMID: 15104289
The Ki-67 protein has an essential role in cell proliferation. It is present in all dividing cells of normal and tumor tissues, but absent in resting cells. At present, no...
5.
Schmidt M, Broll R, Bruch H, Finniss S, Bogler O, Duchrow M
J Cell Biochem . 2004 Mar; 91(6):1280-92. PMID: 15048881
The Ki-67 antigen, pKi-67, is a commonly used proliferation marker in research and pathology. It has been recognized that the protein exists in two different splice variants that differ in...
6.
Schiedeck T, Wellm C, Roblick U, Broll R, Bruch H
Dis Colon Rectum . 2003 Jun; 46(6):818-25. PMID: 12794585
Purpose: The aim of this study was to compare carcinoembryonic antigen levels with detection of messenger ribonucleic acid coding for the tumor-associated antigen L6 in patients with colorectal cancer. Not...
7.
Schmidt M, Broll R, Bruch H, Bogler O, Duchrow M
J Pathol . 2002 Dec; 199(1):18-27. PMID: 12474222
The proliferation marker pKi-67 ('Ki-67 antigen') is commonly used in clinical and research pathology to detect proliferating cells, as it is only expressed during cell-cycle progression. Despite the fact that...
8.
Schmidt M, Broll R, Bruch H, Duchrow M
Histochem Cell Biol . 2002 Nov; 118(5):415-22. PMID: 12432453
The Ki-67 antigen, pKi-67, is one of the most commonly used markers of proliferating cells. The protein can only be detected in dividing cells (G(1)-, S-, G(2)-, and M-phase) but...
9.
Schmidt M, Broll R, Bruch H, Duchrow M
J Cell Biochem . 2002 Oct; 87(3):334-41. PMID: 12397615
The proliferation marker pKi-67 is commonly used in research and pathology to detect proliferating cells. In a previous work, we found the protein to be associated with regulators of the...
10.
Uthoff S, Duchrow M, Schmidt M, Broll R, Bruch H, Strik M, et al.
Int J Cancer . 2002 Sep; 101(1):32-6. PMID: 12209585
We wished to demonstrate vascular endothelial growth factor (VEGF) transcript polymorphism in human colon cancer. RNA was extracted from 25 primary human colorectal adenocarcinomas followed by VEGF transcript amplification, fragment...